Thoracic aortic plaque enhances hypercoagulability in patients with nonrheumatic atrial fibrillation

Circulation Journal

Volumn 71, Issue 1, 2007, Pages 52-56

  Nakagawa, Keiko ^a   Hirai, Tadakazu ^a   Sakurai, Kenji ^a   Ohara, Kazumasa ^a   Nozawa, Takashi ^a   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Aortic atherosclerosis; Atrial fibrillation; Embolism; Hemostatic markers; Transesophageal echocardiography

Indexed keywords

ANTITHROMBIN III; D DIMER; GLOBULIN; PLASMIN; PLASMIN INHIBITOR; PROTHROMBIN; THROMBIN; THROMBOCYTE FACTOR 4; THROMBOGLOBULIN; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROMA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; SINUS RHYTHM; THORACIC AORTA; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ANTIPLASMIN; ANTITHROMBIN III; AORTIC DISEASES; ARRHYTHMIA, SINUS; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BETA-THROMBOGLOBULIN; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PLASMIN; PLATELET FACTOR 4; PROTHROMBIN; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 33845975326     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.52     Document Type: Article

References (27)

1. Lip GYH. Does atrial fibrillation confer a hypercoagulable state? Lancet 1995; 346: 1313-1314.
2. Feng D, D'Agostino RB, Silbershatz H, Lipinska I, Massaro J, Levy D, et al. Hemostatic state and atrial fibrillation (The Framingham Offspring Study). Am J Cardiol 2001; 87: 168-171.
3. Lip GYH, Lip PL, Zarifis J, Watson RD, Bareford D, Lowe GD, et al. Fibrin D-dimer and β-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation: Effects of introducing ultra-low-dose warfarin and aspirin. Circulation 1996; 94: 425-431.
4. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990; 16: 377-380.
5. Yamamoto K, Ikeda U, Fukazawa H, Shimada K. Effects of aspirin on status of thrombin generation in atrial fibrillation. Am J Cardiol 1996; 77: 528-530.
6. Li-Saw-Hee FL, Blann AD, Lip GYH. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. J Am Coll Cardiol 2000; 35: 1926-1931.
7. Tunick PA, Kronzon I. Atheromas of the thoracic aorta: Clinical and therapeutic update. J Am Coll Cardiol 2000; 35: 545-554.
8. Cohen A, Amarenco P. Atherosclerosis of the thoracic aorta: From risk stratification to treatment. Am J Cardiol 2002; 90: 1333-1335.
9. Khatibzadeh M, Mitusch R, Stierle U, Gromoll B, Sheikhzadeh A. Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 1996; 27: 664-669.
10. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiography correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998; 128: 639-647.
11. Nakagawa K, Hirai T, Shinokawa N, Takashima S, Nozawa T, Asanoi H, et al. Aortic spontaneous echocardiographic contrast and hemostatic markers in patients with nonrheumatic atrial fibrillation. Chest 2002; 121: 500-505.
12. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL, et al. Report of the American Society of Echocadiography committee on nomenclature and standards in two-dimensional echocardiography. Circulation 1980; 62: 212-217.
13. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961-969.
14. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996; 334: 1216-1221.
15. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994; 331: 1474-1479.
16. Castello R, Pearson AC, Fagan L, Labovitz AL. Spontaneous echocardiographic contrast in the descending aorta. Am Heart J 1990; 120: 915-919.
17. Finkelhor RS, Lamont WE, Ramanavarapu SK, Bahler RC. Spontaneous echocardiographic contrast in the thoracic aorta: Factors associated with its occurrence and its association with embolic events. Am Heart J 1995; 130: 1254-1258.
18. Finkelhor RS, Youssefi ME, Lamont WE, Bahler RC. Embolic risk based on aortic atherosclerotic morphologic features and aortic spontaneous echocardiographic contrast. Am Heart J 1999; 137: 1088-1093.
19. Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, et al. Markers of thrombin and platelet activity in patients with atrial fibrillation: Correlation with stroke among 1531 participants in The Stroke Prevention in Atrial Fibrillation III study. Stroke 1999; 30: 2547-2553.
20. Ehlermann P, Mirau W, Jahn J, Remppis A, Sheikhzadeh A. Predictive value of inflammatory and hemostatic parameters, athrosclerotic risk factors, and chest X-ray for aortic arch atheromatosis. Stroke 2004; 35: 34-39.
21. Gustafsson C, Blomback M, Britton M, Hamsten A, Srennson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 1990; 21: 47-51.
22. Lip GYH, Lowe GDO, Rumley A, Dunn FG. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: Evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J 1996; 131: 724-730.
23. Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagulation Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457.
24. Inoue H, Nozawa T, Hirai T, Iwasa A, Okumura K, Lee JD, et al. Accumulation of risk factors increases risk of thromboembolic events in patients with nonvalvular atrial fibrillation. Circ J 2006; 70: 651-656.
25. Itani Y, Watanabe S, Masuda Y. Relationship between aortic calcification and stroke in a mass screening program using a mobile helical computed tomography unit. Circ J 2006; 70: 733-736.
26. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 1149-1160.
27. Takano K, Iino K, Ibayashi S, Tagawa K, Sadoshima S, Fujishima M. Hypercoagulable state under low-intensity warfarin anticoagulation assessed with hemostatic markers in cardiac disorders. Am J Cardiol 1994; 74: 935-939.